Interaction between Fibrinogen and IL‐6 Genetic Variants and Associations with Cardiovascular Disease Risk in the Cardiovascular Health Study

The inflammatory cytokine interleukin‐6 (IL‐6) is a main regulator of fibrinogen synthesis, though its interaction with fibrinogen genes (FGA, FGB, FGG) and subsequent impact on cardiovascular disease (CVD) risk is not well‐studied.

[1]  C. Carlson,et al.  Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults , 2008, Thrombosis and Haemostasis.

[2]  B. Cheung,et al.  Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene −572C>G polymorphism in subjects with and without hypertension , 2007, Journal of Human Hypertension.

[3]  A. Reiner,et al.  IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study , 2007, Human Genetics.

[4]  A. Reiner,et al.  Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study , 2007, Journal of thrombosis and haemostasis : JTH.

[5]  G. Lowe,et al.  Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke: The Edinburgh Artery Study , 2007, Circulation.

[6]  Chiara Sabatti,et al.  Human genetics: Variants in common diseases , 2007, Nature.

[7]  Thomas Lumley,et al.  Logic regression for analysis of the association between genetic variation in the renin-angiotensin system and myocardial infarction or stroke. , 2006, American journal of epidemiology.

[8]  M. Rieder,et al.  Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study , 2006, Journal of thrombosis and haemostasis : JTH.

[9]  H. Duan,et al.  Cell Type-specific Differential Induction of the Human γ-Fibrinogen Promoter by Interleukin-6* , 2006, Journal of Biological Chemistry.

[10]  K. Christensen,et al.  Genetic influence on thrombotic risk markers in the elderly – a Danish twin study , 2006, Journal of thrombosis and haemostasis : JTH.

[11]  Per Eriksson,et al.  Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction , 2006, Thrombosis and Haemostasis.

[12]  H. Duan,et al.  Cell type-specific differential induction of the human gamma-fibrinogen promoter by interleukin-6. , 2006, The Journal of biological chemistry.

[13]  W. Kannel.  Overview of hemostatic factors involved in atherosclerotic cardiovascular disease , 2005, Lipids.

[14]  H Tunstall-Pedoe,et al.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.

[15]  M. D. de Maat,et al.  Fibrinogen heterogeneity: inherited and noninherited , 2005, Current opinion in hematology.

[16]  M. D. de Maat,et al.  A Hepatocyte Nuclear Factor-3 Site in the Fibrinogen β Promoter Is Important for Interleukin 6-induced Expression, and Its Activity Is Influenced by the Adjacent –148C/T Polymorphism* , 2005, Journal of Biological Chemistry.

[17]  K. Christensen,et al.  Genetic Influence on Inflammation Variables in the Elderly , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[18]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.

[19]  H. Duan,et al.  Functional Analysis of Interleukin 6 Response Elements (IL-6REs) on the Human γ-Fibrinogen Promoter , 2003, Journal of Biological Chemistry.

[20]  P. Simpson‐Haidaris,et al.  Functional analysis of interleukin 6 response elements (IL-6REs) on the human gamma-fibrinogen promoter: binding of hepatic Stat3 correlates negatively with transactivation potential of type II IL-6REs. , 2003, The Journal of biological chemistry.

[21]  M. LeBlanc,et al.  Logic Regression , 2003 .

[22]  D. Levy,et al.  A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study. , 2003, Thrombosis research.

[23]  S. Humphries,et al.  In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[24]  G. Fuller,et al.  Transcriptional Control Mechanism of Fibrinogen Gene Expression , 2001, Annals of the New York Academy of Sciences.

[25]  T. Spector,et al.  The genetics of haemostasis: a twin study , 2001, The Lancet.

[26]  C Kooperberg,et al.  Sequence Analysis Using Logic Regression , 2001, Genetic epidemiology.

[27]  A. Hamsten,et al.  Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[28]  S. Humphries,et al.  Gene-Environment Interaction in the Determination of Levels of Plasma Fibrinogen , 1999, Thrombosis and Haemostasis.

[29]  G. Fuller,et al.  Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. , 1998, Blood.

[30]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[31]  P. Haidaris.  Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. , 1997, Blood.

[32]  Scott A. Williams,et al.  Characterization of the 5′ Flanking Region of the Human Complement Factor H Gene , 1997, Scandinavian journal of immunology.

[33]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.

[34]  E. Davie,et al.  Characterization of the 5′-Flanking Region of the Gene for the α Chain of Human Fibrinogen (*) , 1995, The Journal of Biological Chemistry.

[35]  K. Loeb,et al.  Characterization of the 5′-Flanking Region of the Gene for the γChain of Human Fibrinogen (*) , 1995, The Journal of Biological Chemistry.

[36]  G. Fuller,et al.  Characterization of the IL-6 Responsive Elements in the γ Fibrinogen Gene Promoter (*) , 1995, The Journal of Biological Chemistry.

[37]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[38]  Zhiyong Liu,et al.  Detection of a Novel Transcription Factor for the Aα Fibrinogen Gene in Response to Interleukin-6 (*) , 1995, The Journal of Biological Chemistry.

[39]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[40]  T. Reed,et al.  Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study , 1994, Clinical genetics.

[41]  E. Ernst.  The role of fibrinogen as a cardiovascular risk factor. , 1993, Atherosclerosis.

[42]  G. Courtois,et al.  The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element , 1993, Molecular and cellular biology.

[43]  B M Psaty,et al.  Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1991, Stroke.

[44]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[45]  P. Huber,et al.  Human beta-fibrinogen gene expression. Upstream sequences involved in its tissue specific expression and its dexamethasone and interleukin 6 stimulation. , 1990, The Journal of biological chemistry.

[46]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[47]  H. Grenett,et al.  The coordinated regulation of fibrinogen gene transcription by hepatocyte-stimulating factor and dexamethasone , 1987, Journal of Cell Biology.